Skip to main content
OpenTrials
Completed

NCT Number: NCT06060691

the Ameliorating Effects of Antioxidant Gel on Female Arousal Disorder and Sexual Dysfunction

The aim of this study is to evaluate the quality of sexual life of females with sexual interest or arousal disorder before and after accurate application of a formulated emulgel made from natural ingredients, including kaempferol as an API

Completed

Looking for future studies?

Notify Me

Key information

Age range

28 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 1

Primary location

Soad A. Mohamad

Minya, 05673, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women between the ages of 28 and 45
  • had regular periods and previous menstrual bleeding lasted between three and seven days

Exclusion criteria

  • sensitivity to drug of therapy,
  • cancer,
  • autoimmune illness,
  • smoking or drinking,
  • liver disease,
  • irregular menstruation

Treatment and study plan

Kaempferol

Drug

Kaempferol

Primary outcomes

  1. Female Sexual Function Index

    Time frame: two months

    The FSFI comprises 19 questions of sexual function in six independent areas consisting of desire, arousal, lubrication, orgasm, sexual satisfaction , pain from sex.

Sponsors and collaborators

Lead sponsor

Deraya University

Other

Registry information

Official study title

Randomized Controlled Trial Studying the Ameliorating Effects of Kaempferol Emulgel on Female Arousal Disorder and Sexual Dysfunction

Important dates

Study start
2023
Primary completion
2023
Study completion
2024
First posted
Sep 29, 2023
Registry last updated
May 16, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.